Intratumor heterogeneity in EGFR-mutant lung tumors mediates targeted therapy resistance and formation of drug tolerant microenvironment

被引：0
|
作者：
Haikala, Heidi M.
Alsaed, Bassel
Son, Jieun
Lin, Linh
Gokhale, Prafulla
Janne, Pasi
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1989
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1989
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy
    Lim, Zuan-Fu
    Ma, Patrick C.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)
  • [32] Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy
    Zuan-Fu Lim
    Patrick C. Ma
    Journal of Hematology & Oncology, 12
  • [33] Neoadjuvant targeted therapy for resectable EGFR-mutant non-small cell lung cancer: Current status and future considerations
    Liu, Wenliang
    Ren, Siying
    Xiao, Ying
    Yang, Lulu
    Zeng, Chao
    Hu, Yan
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [34] Does neoadjuvant targeted therapy provide an opportunity for resectable EGFR-mutant lung cancer: a real-world retrospective study
    Lv, Chao
    Ma, Yuanyuan
    Feng, Qin
    Lu, Fangliang
    Chi, Yongkun
    Wu, Nan
    Fang, Jian
    Yang, Yue
    JOURNAL OF THORACIC DISEASE, 2020, 12 (10) : 5324 - +
  • [35] Histologic Characterization of Small Cell Transformation from EGFR-Mutant Non-Small Cell Lung Carcinoma after EGFR-Targeted Therapy
    Lepus, Christin
    Rotow, Julia
    Janne, Pasi
    Sholl, Lynette
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1796 - 1797
  • [36] SLC12A8 mediates TKI resistance in EGFR-mutant lung cancer via PDK1/AKT axis
    Huang, Fang
    Cui, Jian
    Wan, Jingxuan
    Yuan, Xue
    Zhu, Yuanzhe
    Wu, Xiangxiang
    Zuo, Wei
    Zhao, Tiantian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (18) : 16729 - 16739
  • [37] SLC12A8 mediates TKI resistance in EGFR-mutant lung cancer via PDK1/AKT axis
    Fang Huang
    Jian Cui
    Jingxuan Wan
    Xue Yuan
    Yuanzhe Zhu
    Xiangxiang Wu
    Wei Zuo
    Tiantian Zhao
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 16729 - 16739
  • [38] Met/Ror1-13-catenin-Bc1-xL axis contributes to the emergence of drug -tolerant cells that evolve into resistant tumors in EGFR-mutant lung cancer
    Fujii, Masanori
    Nakayama, Sohei
    Akanuma, Naoki
    Pan, Gilbert
    Kobayashi, Ikei S.
    Takei, Hisashi
    Shimizu, Kohei
    Ando, Mariko
    Heo, Eunyoung
    Gergis, Carol
    Inuzuka, Hiroyuki
    Wei, Wenyi
    Costa, Daniel B.
    Kobayashi, Susumu S.
    CANCER RESEARCH, 2019, 79 (13)
  • [39] Genotype-Fitness Maps of EGFR-Mutant Lung Adenocarcinoma Chart the Evolutionary Landscape of Resistance for Combination Therapy Optimization
    Bolan, Patrick O.
    Zviran, Asaf
    Brenan, Lisa
    Schiffman, Joshua S.
    Dusaj, Neville
    Goodale, Amy
    Piccioni, Federica
    Johannessen, Cory M.
    Landau, Dan A.
    CELL SYSTEMS, 2020, 10 (01) : 52 - +
  • [40] Histologic Characterization of Small Cell Transformation from EGFR-Mutant Non-Small Cell Lung Carcinoma after EGFR-Targeted Therapy
    Lepus, Christin
    Rotow, Julia
    Janne, Pasi
    Sholl, Lynette
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1796 - 1797
12345